Kenneth X. Sooi
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.
Journal: Thoracic cancer
Published: April 26, 2026
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 31, 2026
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges.
Journal: Expert review of anticancer therapy
Published: February 08, 2026
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: April 14, 2025
A phase 1b, multicentre, dose escalation, safety and pharmacokinetics study of tilvestamab (BGB149) in relapsed, platinum-resistant, high-grade serous ovarian cancer (PROC) patients.
Journal: British journal of cancer
Published: December 23, 2024
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 30, 2024
Modulating the gut microbiome in non-small cell lung cancer: Challenges and opportunities.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 15, 2024
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: May 20, 2023
Resectable non-small cell lung cancer: an evolving landscape.
Journal: Translational lung cancer research
Published: July 13, 2022
Real-world assessment of attenuated dosing anti-PD1 therapy as an alternative dosing strategy in a high-income country (as defined by World Bank).
Journal: Frontiers in oncology
Published: April 29, 2022
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer.
Journal: International journal of cancer
Published: October 07, 2020
Powered Air Purifying Respirator (PAPR) restores the N95 face mask induced cerebral hemodynamic alterations among Healthcare Workers during COVID-19 Outbreak.
Journal: Journal of the neurological sciences
Published: June 16, 2020
Last Updated: 09/26/2026